Avanos Medical (AVNS) Competitors

$20.39
-0.03 (-0.15%)
(As of 05/17/2024 ET)

AVNS vs. ZJYL, ESTA, SMTI, ENOV, PRAX, RLAY, ETNB, OPK, IMTX, and MESO

Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include Jin Medical International (ZJYL), Establishment Labs (ESTA), Sanara MedTech (SMTI), Enovis (ENOV), Praxis Precision Medicines (PRAX), Relay Therapeutics (RLAY), 89bio (ETNB), OPKO Health (OPK), Immatics (IMTX), and Mesoblast (MESO). These companies are all part of the "medical" sector.

Avanos Medical vs.

Jin Medical International (NASDAQ:ZJYL) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk.

Avanos Medical received 83 more outperform votes than Jin Medical International when rated by MarketBeat users.

CompanyUnderperformOutperform
Jin Medical InternationalN/AN/A
Avanos MedicalOutperform Votes
83
54.97%
Underperform Votes
68
45.03%

Jin Medical International has higher earnings, but lower revenue than Avanos Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical InternationalN/AN/AN/AN/AN/A
Avanos Medical$673.30M1.39-$61.80M-$1.33-15.33

Jin Medical International has a net margin of 0.00% compared to Jin Medical International's net margin of -9.15%. Jin Medical International's return on equity of 4.10% beat Avanos Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Avanos Medical -9.15%4.10%2.99%

Jin Medical International has a beta of 18.8, indicating that its stock price is 1,780% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.

Avanos Medical has a consensus price target of $31.00, suggesting a potential upside of 52.04%. Given Jin Medical International's higher possible upside, analysts plainly believe Avanos Medical is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Avanos Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

95.2% of Avanos Medical shares are held by institutional investors. 2.9% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Avanos Medical had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Avanos Medical and 0 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.84 beat Avanos Medical's score of 0.00 indicating that Avanos Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
Avanos Medical Positive

Summary

Avanos Medical beats Jin Medical International on 10 of the 12 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVNS vs. The Competition

MetricAvanos MedicalSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$935.90M$9.12B$5.16B$18.11B
Dividend YieldN/A1.36%43.85%3.44%
P/E Ratio-15.3315.01123.8722.87
Price / Sales1.3948.802,371.5111.34
Price / Cash10.1021.2236.3719.45
Price / Book0.7616.705.746.01
Net Income-$61.80M$182.64M$105.71M$966.65M
7 Day Performance4.14%1.94%1.84%1.85%
1 Month Performance9.04%2.07%4.72%7.14%
1 Year Performance-10.49%-13.15%7.80%21.67%

Avanos Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZJYL
Jin Medical International
0 of 5 stars
$3.25
-10.0%
N/A-46.0%$503.75MN/A0.00269
ESTA
Establishment Labs
0.275 of 5 stars
$53.94
-0.8%
$55.00
+2.0%
-18.1%$1.48B$165.15M-17.74908
SMTI
Sanara MedTech
1.0436 of 5 stars
$33.50
+2.9%
$44.00
+31.3%
-19.8%$288.77M$64.99M-64.42107Analyst Forecast
Analyst Revision
News Coverage
ENOV
Enovis
2.7824 of 5 stars
$52.24
+2.6%
$75.43
+44.4%
-6.1%$2.87B$1.71B-34.836,550Short Interest ↑
PRAX
Praxis Precision Medicines
1.5122 of 5 stars
$52.40
-1.4%
$105.80
+101.9%
+185.5%$896.56M$2.45M-2.2182Analyst Forecast
Analyst Revision
News Coverage
RLAY
Relay Therapeutics
2.952 of 5 stars
$6.74
-4.5%
$24.00
+256.1%
-35.9%$894.67M$25.55M-2.55323
ETNB
89bio
2.1947 of 5 stars
$9.37
-2.3%
$29.00
+209.5%
-51.1%$892.21MN/A-4.6670Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
OPK
OPKO Health
4.3421 of 5 stars
$1.30
-1.5%
$3.17
+143.6%
-19.5%$906.09M$863.50M-5.203,930Analyst Upgrade
Insider Buying
Options Volume
News Coverage
IMTX
Immatics
1.4795 of 5 stars
$10.72
-0.2%
N/A+9.9%$907.56M$58.44M-8.25432Upcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
Gap Up
MESO
Mesoblast
1.4265 of 5 stars
$7.96
-0.6%
$13.67
+71.8%
-3.8%$908.30M$7.50M-7.1083Upcoming Earnings

Related Companies and Tools

This page (NYSE:AVNS) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners